Outpatient intravenous antibiotic treatment;Tratamiento antibiótico parenteral en el paciente ambulatorio

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue 7, 2005, Pages 393-395

  Garde, Carmen ^a   Goenaga, Miguel Ángel ^a  

^a ACCURA UHD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIDOFOVIR; DAPTOMYCIN; ERTAPENEM; LEVOFLOXACIN; LINEZOLID; TEICOPLANIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; EDITORIAL; OUTPATIENT; PRACTICE GUIDELINE;

EID: 25844442336     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13078796     Document Type: Editorial

References (26)

1. Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, et al. Practice Guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;38:1651-72.
2. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54:358-60.
3. Antoniskis A, Anderson BC, Von Volkinburg EJ, Jackson JH, Gilbert DN. Feasibility of outpatient self administration of parenteral antibiotics. West J Med. 1978;128:203-6.
4. Antelo MC, Pestana A. Terapéutica antibiótica intravenosa domiciliaria en niños con fibrosis quística. An Esp Pediatr. 1988;28 Supl 31:55.
5. Hazas J, Fernández-Miera MF, Sampedro I, Fariñas MC, García de la Paz AM, Sanroma P. Antibioterapia intravenosa domiciliaria. Enferm Infecc Microbiol Clin. 1998;16:465-70.
6. Goenaga MA, Garde C, Millet M, Carrera JA. Tratamientos antimicrobianos parenterales en domicilio. Experiencia de 5 años. Rev Clin Esp. 2002;202:142-7.
7. Basterretxea A, Goenaga MA, Gómez M, Millet M, De Damborenea D, Carrera JA, Garde C, et al. Tratamientos antibióticos intravenosos en domicilio (TAID): Experiencia con más de 1.000 casos. En: Libro de Comunicaciones del VI Congreso Nacional de Hospitalización a Domicilio. Barcelona 19-21 de septiembre de 2002:10.
8. Girón RM, Martínez A, Maíz L, Salcedo A, Beltrán B, Martínez MT, et al. Tratamiento antibiótico intravenose domiciliario en las unidades de fibrosis quística de la Comunidad de Madrid. Med Clin (Barc). 2004;122:648-52.
9. Mendoza H, Casas J, Martínez-Martínez C, De la Maza I, Regalado de los Cobos J, Cía JM. Antibioterapia intravenosa en domicilio. Estudio de 515 casos. Enferm Infecc Microbiol Clin. 2005;23:396-401.
10. Poretz DM. Evolution of outpatient parenteral antibiotic therapy. Infect Dis Clin North Am. 1998;12:827-34.
11. Goenaga MA, Garde C, Millet M, Carrera JA, Arzelus E, Sánchez E. Ahorro de estancias hospitalarias con los tratamientos antibióticos parenterales en domicilio (TAPD) ¿Es tanto como parece? En: Libro de Ponencias y Comunicaciones del 7.o Congreso Nacional de Hospitalización a Domicilio. Vigo, 3-4 de junio de 2004:191.
12. Chamberlain TM, Lehman ME, Groh MJ, Munroe WP, Reinders TP. Cost analysis of a home intravenous antibiotic program. Am J Hosp Pharm. 1988; 45:2341-5.
13. Balinsky W, Nesbitt S. Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature. Am J Med. 1989;87:301-5.
14. Thickson ND. Economics of home intravenous services. Pharmacoeconomics. 1993;3:220-7.
15. Hindes R, Winkler C, Kane P, Kunkel M. Outpatient intravenous antibiotic therapy in medicare patients: cost-savings analysis. Infect Dis Clin Pract. 1995;4:211-7.
16. Dalovisio JR, Juneau J, Baumgartem K, Kateiva J. Financial impact of a home intravenous antibiotic program on a Medicare managed care program. Clin infect Dis. 2000;30:639-42.
17. Wai AO, Frighetto L, Marra CA, Chan E, Jewesson PJ. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Pharmacoeconomics. 2000;18:451-7.
18. Tice AD, Hoaglund PA, Nolet B, McKinnon PS, Mozaffari E. Cost perspectives for outpatient intravenous antimicrobial therapy. Pharmacotherapy. 2002;22:63S-70S.
19. Tice A. Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy. J Antimicrob Chemother. 2004;53 Supl 2:1183-6.
20. Gesser RM, McCarroll KA, Woods GL. Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structures infections. J Infect. 2004;48:32-8.
21. Andes D, Craig WA. Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy. Infect Dis Clin North Am. 1998;12:849-60.
22. Slavik RS, Jewesson PJ. Selecting antibacterials for outpatient parenteral antimicrobial therapy: pharmacokinetic-pharmacodynamic consideration. Clin Pharmacokinet. 2003;42:793-817.
23. Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, et al. International OPAT Registry. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents. 2004;24:473-8.
24. Goenaga MA, Millet M, Garde C, Carrera JA, Arzelus E. About the guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;39:1730-1.
25. Corwin P, Toop L, McGeoch G, Than M, Wynn-Thomas S, Wells JE, et al. Randomized controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ. doi:101136/bmj.38309.447975.EB (published 16 December 2004).
26. Eron L, King P, Marineau M, Yonehara C. Treating acute infections by telemedicine in the home. Clin Infect Dis. 2004;39:1175-81.